High throughput transcriptomics suggested that dodecafluorpentan protected against AKI by suppressing the nuclear translocation of NFκB and inhibiting the subsequent activation of NLRP3 inflammasome in renal tubular epithelial cells. Here, NFKB1 is linked to acute kidney injury.